Late-onset neutropenia in a multiple sclerosis patient after first dose ocrelizumab switched from rituximab.

Research output: Contribution to journal › Communication

22 Citations (Web of Science)

Original language	English
Journal	Multiple Sclerosis and Related Disorders
DOIs	https://doi.org/10.1016/j.msard.2020.102155
Publication status	Published - 2020

Branches of science

@article{d363dcf8afa34e9e9588c168f7288726,

title = "Late-onset neutropenia in a multiple sclerosis patient after first dose ocrelizumab switched from rituximab.",

author = "M Auer and G Bsteh and H Hegen and Sebastian Wurth and A Zinganell and T Berger and F Deisenhammer and FD Pauli",

year = "2020",

doi = "10.1016/j.msard.2020.102155",

language = "English",

journal = "Multiple Sclerosis and Related Disorders",

issn = "2211-0348",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Late-onset neutropenia in a multiple sclerosis patient after first dose ocrelizumab switched from rituximab.

AU - Auer, M

AU - Bsteh, G

AU - Hegen, H

AU - Wurth, Sebastian

AU - Zinganell, A

AU - Berger, T

AU - Deisenhammer, F

AU - Pauli, FD

PY - 2020

Y1 - 2020

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000548665900013

UR - https://pubmed.ncbi.nlm.nih.gov/32470856

U2 - 10.1016/j.msard.2020.102155

DO - 10.1016/j.msard.2020.102155

M3 - Communication

C2 - 32470856

SN - 2211-0348

JO - Multiple Sclerosis and Related Disorders

JF - Multiple Sclerosis and Related Disorders

ER -